{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:11Z","timestamp":1792174991244,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI20\/01169"],"award-info":[{"award-number":["PI20\/01169"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016778","name":"Paradifference foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01490"],"award-info":[{"award-number":["PI22\/01490"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01169"],"award-info":[{"award-number":["PI20\/01169"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bbcan.2024.189141","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T21:18:49Z","timestamp":1718918329000},"page":"189141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma"],"prefix":"10.1016","volume":"1879","author":[{"given":"Alberto","family":"Casc\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbcan.2024.189141_bb0005","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0167","article-title":"Genetic bases of pheochromocytoma and paraganglioma","volume":"70","author":"Cascon","year":"2023","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189141_bb0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189141_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Group NGSiPS","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189141_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189141_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113304","article-title":"Novel DNMT3A germline variant in a patient with multiple Paragangliomas and papillary thyroid carcinoma","volume":"12","author":"Mellid","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bbcan.2024.189141_bb0030","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189141_bb0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14222","article-title":"Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up","volume":"93","author":"Kittah","year":"2020","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0040","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1210\/clinem\/dgaa741","article-title":"Genotype-phenotype features of germline variants of the TMEM127 Pheochromocytoma susceptibility gene: a 10-year update","volume":"106","author":"Armaiz-Pena","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189141_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2024.189141_bb0050","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of Paragangliomas and Pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PAP.0000000000000365","article-title":"Advances in adrenal and extra-adrenal Paraganglioma: practical synopsis for pathologists","volume":"30","author":"Juhlin","year":"2023","journal-title":"Adv. Anat. Pathol."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189141_bb0070","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189141_bb0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European network for the study of adrenal tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189141_bb0080","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1210\/jc.2014-1870","article-title":"SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma\/paraganglioma","volume":"100","author":"Menara","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189141_bb0085","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189141_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Recurrent germline DLST mutations in individuals with multiple Pheochromocytomas and Paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189141_bb0095","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189141_bb0100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189141_bb0115","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline mutations in the mitochondrial 2-Oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic Paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189141_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000001945","article-title":"A Clinicopathologic and molecular analysis of fumarate hydratase-deficient Pheochromocytoma and Paraganglioma","volume":"47","author":"Fuchs","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189141_bb0135","first-page":"69","article-title":"Metabologenomics of Phaeochromocytoma and Paraganglioma: an integrated approach for personalised biochemical and genetic testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin. Biochem. Rev."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189141_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","article-title":"Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma","volume":"21","author":"Richter","year":"2019","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189141_bb0145","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2014-2151","article-title":"Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency","volume":"99","author":"Richter","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jnci\/djab158","article-title":"Germline SUCLG2 variants in patients with Pheochromocytoma and Paraganglioma","volume":"114","author":"Hadrava Vanova","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"issue":"20","key":"10.1016\/j.bbcan.2024.189141_bb0155","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted exome sequencing of Krebs cycle genes reveals candidate cancer\u2013predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189141_bb0160","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a Hallmark of SDHx mutations in Paraganglioma","volume":"22","author":"Lussey-Lepoutre","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189141_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00191","article-title":"Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility","volume":"2","author":"Casey","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189141_bb0170","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"Lopez-Jimenez","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet."},{"issue":"49","key":"10.1016\/j.bbcan.2024.189141_bb0180","doi-asserted-by":"crossref","first-page":"48690","DOI":"10.1074\/jbc.M308862200","article-title":"The von Hippel Lindau\/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen","volume":"278","author":"del Peso","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189141_bb0185","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41436-018-0003-y","article-title":"Gain-of-function mutations in DNMT3A in patients with paraganglioma","volume":"20","author":"Remacha","year":"2018","journal-title":"Genet. Med."},{"issue":"26","key":"10.1016\/j.bbcan.2024.189141_bb0190","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas","volume":"21","author":"Welander","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189141_bb0195","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-Mendez","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189141_bb0200","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00109-015-1306-y","article-title":"Functional and in silico assessment of MAX variants of unknown significance","volume":"93","author":"Comino-Mendez","year":"2015","journal-title":"J. Mol. Med. (Berl)"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189141_bb0205","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa396","article-title":"Functional characterization of TMEM127 variants reveals novel insights into its membrane topology and trafficking","volume":"105","author":"Flores","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189141_bb0210","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41436-018-0068-7","article-title":"Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients","volume":"20","author":"Calsina","year":"2018","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0215","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189141_bb0220","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/PO.21.00127","article-title":"Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with Selpercatinib in malignant Pheochromocytoma","volume":"5","author":"Mweempwa","year":"2021","journal-title":"JCO Precis. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189141_bb0225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","article-title":"Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in carney triad","volume":"21","author":"Haller","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2024.189141_bb0230","first-page":"jc20153856","article-title":"Epigenetic mutation of the succinate dehydrogenase C promoter in a patient with two paragangliomas","author":"Richter","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189141_bb0235","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189141_bb0240","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in Pheochromocytomas and Paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189141_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12881-014-0111-8","article-title":"Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations","volume":"15","author":"Bayley","year":"2014","journal-title":"BMC Med. Genet."},{"issue":"7831","key":"10.1016\/j.bbcan.2024.189141_bb0250","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189141_bb0255","first-page":"52","article-title":"Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users\u2019 views","volume":"9","author":"Bertier","year":"2016","journal-title":"BMC Med. Genet."}],"updated-by":[{"DOI":"10.1016\/j.bbcan.2025.189321","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:06:39Z","timestamp":1762290399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0304419X24000726"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189141","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189141"}}